ArticleTranslational lung cancer research2024

Phase II study of ramucirumab and docetaxel for previously platinum-treated patients with non-small cell lung cancer and malignant pleural effusion (PLEURAM study).

Shinnosuke Takemoto et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.